{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:47:50Z","timestamp":1790401670519,"version":"4.1.0"},"reference-count":36,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T00:00:00Z","timestamp":1614297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014364","name":"Samsung Science and Technology Foundation","doi-asserted-by":"publisher","award":["SRFC-MA1802-09"],"award-info":[{"award-number":["SRFC-MA1802-09"]}],"id":[{"id":"10.13039\/501100014364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Human cytomegalovirus (CMV) infection is widespread among adults (60\u201390%) and is usually undetected in healthy individuals without symptoms but can cause severe diseases in immunocompromised hosts. T-cell receptor (TCR)-like antibodies (Abs), which recognize complex antigens (peptide\u2013MHC complex, pMHC) composed of MHC molecules with embedded short peptides derived from intracellular proteins, including pathogenic viral proteins, can serve as diagnostic and\/or therapeutic agents. In this study, we aimed to engineer a TCR-like Ab specific for pMHC comprising a CMV pp65 protein-derived peptide (495NLVPMVATV503; hereafter, CMVpp65495-503) in complex with MHC-I molecule human leukocyte antigen (HLA)-A*02:01 (CMVpp65495-503\/HLA-A*02:01) to increase affinity by sequential mutagenesis of complementarity-determining regions using yeast surface display technology. Compared with the parental Ab, the final generated Ab (C1-17) showed ~67-fold enhanced binding affinity (KD \u2248 5.2 nM) for the soluble pMHC, thereby detecting the cell surface-displayed CMVpp65495-503\/HLA-A*02:01 complex with high sensitivity and exquisite specificity. Thus, the new high-affinity TCR-like Ab may be used for the detection and treatment of CMV infection.<\/jats:p>","DOI":"10.3390\/ijms22052349","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T09:47:20Z","timestamp":1614332840000},"page":"2349","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Affinity Maturation of a T-Cell Receptor-Like Antibody Specific for a Cytomegalovirus pp65-Derived Peptide Presented by HLA-A*02:01"],"prefix":"10.3390","volume":"22","author":[{"given":"Se-Young","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok-Han","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jeong","family":"Son","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ah","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2967-8432","authenticated-orcid":false,"given":"Keunok","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2673-1509","authenticated-orcid":false,"given":"Yong-Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Molecular Science and Technology, Ajou University, Suwon 16499, Korea"},{"name":"Department of Allergy and Clinical Immunology, Ajou University School of Medicine, Suwon 16499, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,2,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Limaye, A.P., Babu, T.M., and Boeckh, M. (2021). Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation. Clin. Microbiol. Rev., 34.","DOI":"10.1128\/CMR.00043-19"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev. Med. Virol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Lerias, J.R., Paraschoudi, G., Silva, I., Martins, J., de Sousa, E., Condeco, C., Figueiredo, N., Carvalho, C., Dodoo, E., and Jager, E. (2019). Clinically Relevant Immune Responses against Cytomegalovirus: Implications for Precision Medicine. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20081986"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1146\/annurev.immunol.21.120601.141036","article-title":"Molecular interactions mediating T cell antigen recognition","volume":"21","author":"Davis","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"7569","DOI":"10.1128\/jvi.70.11.7569-7579.1996","article-title":"The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL","volume":"70","author":"Wills","year":"1996","journal-title":"J. Virol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/JVI.73.3.2099-2108.1999","article-title":"The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo","volume":"73","author":"Weekes","year":"1999","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1107\/S1744309109037890","article-title":"Crystallization and preliminary X-ray crystallographic characterization of a public CMV-specific TCR in complex with its cognate antigen","volume":"65","author":"Reiser","year":"2009","journal-title":"Acta Cryst. Sect. F Struct. Biol. Cryst. Commun."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00262-020-02564-1","article-title":"Characterization of an HLA-restricted and human cytomegalovirus-specific antibody repertoire with therapeutic potential","volume":"69","author":"Bewarder","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1074\/jbc.RA118.007187","article-title":"Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display","volume":"294","author":"Wagner","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hoydahl, L.S., Frick, R., Sandlie, I., and Loset, G.A. (2019). Targeting the MHC Ligandome by Use of TCR-Like Antibodies. Antibodies, 8.","DOI":"10.3390\/antib8020032"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13045-019-0788-4","article-title":"TCR-like antibodies in cancer immunotherapy","volume":"12","author":"He","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/eji.200939875","article-title":"Direct visualization of the dynamics of antigen presentation in human cells infected with cytomegalovirus revealed by antibodies mimicking TCR specificity","volume":"40","author":"Makler","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Lefranc, M.P., and Lefranc, G. (2020). Immunoglobulins or Antibodies: IMGT((R)) Bridging Genes, Structures and Functions. Biomedicines, 8.","DOI":"10.3390\/biomedicines8090319"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/bioinformatics\/btv552","article-title":"ANARCI: Antigen receptor numbering and receptor classification","volume":"32","author":"Dunbar","year":"2016","journal-title":"Bioinformatics"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lefranc, M.P., Giudicelli, V., Duroux, P., Jabado-Michaloud, J., Folch, G., Aouinti, S., Carillon, E., Duvergey, H., Houles, A., and Paysan-Lafosse, T. (2015). IMGT(R), The international ImMunoGeneTics information system(R) 25 years on. Nucleic Acid. Res., 43.","DOI":"10.1093\/nar\/gku1056"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1038\/s41598-019-44253-9","article-title":"Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity","volume":"9","author":"Kim","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"593748","DOI":"10.3389\/fimmu.2020.593748","article-title":"Engineering of Humanized Antibodies Against Human Interleukin 5 Receptor Alpha Subunit That Cause Potent Antibody-Dependent Cell-Mediated Cytotoxicity","volume":"11","author":"Kim","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.4049\/jimmunol.178.10.6280","article-title":"Disulfide bond engineering to trap peptides in the MHC class I binding groove","volume":"178","author":"Truscott","year":"2007","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1158\/1535-7163.MCT-16-0207","article-title":"A New Class of Bifunctional Major Histocompatibility Class I Antibody Fusion Molecules to Redirect CD8 T Cells","volume":"15","author":"Schmittnaegel","year":"2016","journal-title":"Mol. Cancer. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1002\/1521-4141(2000)30:8<2216::AID-IMMU2216>3.0.CO;2-7","article-title":"Identification of tumor-associated MHC class I ligands by a novel T cell-independent approach","volume":"30","author":"Schirle","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nbt1070","article-title":"Directed evolution of human T-cell receptors with picomolar affinities by phage display","volume":"23","author":"Li","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Manning, C.F., Bundros, A.M., and Trimmer, J.S. (2012). Benefits and pitfalls of secondary antibodies: Why choosing the right secondary is of primary importance. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0038313"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","article-title":"IgG subclasses and allotypes: From structure to effector functions","volume":"5","author":"Vidarsson","year":"2014","journal-title":"Front. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000479238","article-title":"Robust Production of Cytomegalovirus pp65-Specific T Cells Using a Fully Automated IFN-gamma Cytokine Capture System","volume":"45","author":"Kim","year":"2018","journal-title":"Transfus. Med. Hemother."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fimmu.2020.00257","article-title":"TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens","volume":"11","author":"Akatsuka","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9923","DOI":"10.1038\/s41598-017-10265-6","article-title":"TCR-like antibodies mediate complement and antibody-dependent cellular cytotoxicity against Epstein-Barr virus-transformed B lymphoblastoid cells expressing different HLA-A*02 microvariants","volume":"7","author":"Lai","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1038\/leu.2015.125","article-title":"Affinity maturation of T-cell receptor-like antibodies for Wilms tumor 1 peptide greatly enhances therapeutic potential","volume":"29","author":"Zhao","year":"2015","journal-title":"Leukemia"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/19420862.2017.1302630","article-title":"TCR-like antibody drug conjugates mediate killing of tumor cells with low peptide\/HLA targets","volume":"9","author":"Lowe","year":"2017","journal-title":"mAbs"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1086\/339963","article-title":"Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype","volume":"185","author":"Khan","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Gerna, G., Kabanova, A., and Lilleri, D. (2019). Human Cytomegalovirus Cell Tropism and Host Cell Receptors. Vaccines, 7.","DOI":"10.3390\/vaccines7030070"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0065-3527(08)60073-1","article-title":"Cell types involved in replication and distribution of human cytomegalovirus","volume":"46","author":"Plachter","year":"1996","journal-title":"Adv. Virus Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1126\/science.1227919","article-title":"Decoding human cytomegalovirus","volume":"338","author":"Weisburd","year":"2012","journal-title":"Science"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1038\/ncomms15090","article-title":"Antibody targeting intracellular oncogenic Ras mutants exerts anti-tumour effects after systemic administration","volume":"8","author":"Shin","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Shin, S.M., Kim, J.S., Park, S.W., Jun, S.Y., Kweon, H.J., Choi, D.K., Lee, D., Cho, Y.B., and Kim, Y.S. (2020). Direct targeting of oncogenic RAS mutants with a tumor-specific cytosol-penetrating antibody inhibits RAS mutant-driven tumor growth. Sci. Adv., 6.","DOI":"10.1126\/sciadv.aay2174"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1158\/2326-6066.CIR-19-0143","article-title":"A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells","volume":"8","author":"Jung","year":"2020","journal-title":"Cancer Immunol. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/5\/2349\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T05:29:36Z","timestamp":1760160576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/5\/2349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,26]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,3]]}},"alternative-id":["ijms22052349"],"URL":"https:\/\/doi.org\/10.3390\/ijms22052349","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,26]]}}}